Member News

National Academy elects Pfeffer and Schiffer

ASBMB Today Staff
July 29, 2024
portrait of Susan Pfeffer
Susan Pfeffer
Portrait of Celia Schiffer
Celia Schiffer

The National Academy of Sciences recently elected 144 new members, including two American Society for Biochemistry and Molecular Biology members, Suzanne Pfeffer and Celia Schiffer. These scientists are being recognized for their distinguished and continuing achievements in original research.

Pfeffer is a professor of biochemistry at Stanford University School of Medicine. Her research focuses on understanding the molecular basis of inherited Parkinson's disease, with a specific interest in LRRK2 kinase mutations and the Rab GTPases. The Pfeffer lab is also interested in cholesterol transport and how mutations in this pathway can lead to Niemann–Pick disease. Pfeffer is a past president of ASBMB. She is a fellow of the American Association for the Advancement of Science, the American Academy of Arts and Sciences and the American Society for Cell Biology.

Schiffer is a professor and the chair of biochemistry and molecular biotechnology and the director of the institute for drug resistance  at the University of Massachusetts Chan Medical School. Her research focuses on the molecular basis of drug resistance, studying how mutations in drug target enzymes allow them to continue to process their substrates but avoid binding inhibitors. Through this effort, she has defined what she calls the “substrate envelope,” which allows her lab and others to use structure-based drug design to design robust inhibitors that are less apt to be susceptible to resistance. Schiffer received the ASBMB William Rose Award in 2020 and is a fellow of the American Academy of Microbiology.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.